<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=650&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="130805" class="table-">
                
                <td>July 23, 2021, 10:30 p.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo, Day 21 - Phase 1;SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2187, &quot;treatment_name&quot;: &quot;Placebo&quot;, &quot;treatment_type&quot;: &quot;Placebo&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;25 \u03bcg;2;day 0-21&quot;, &quot;treatment_id&quot;: 1159, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs)&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;5 \u03bcg+50 \u03bcg Matrix-M;2;day 0-21&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;25 \u03bcg+50 \u03bcg Matrix-M;2;day0-21&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;25 \u03bcg+50 \u03bcg Matrix-M;1;followed by one dose of placebo on day 21&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;5 \u03bcg+50 \u03bcg Matrix-M;2;day0-21 followed by one dose of placebo on day 189&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;5 \u03bcg+50 \u03bcg Matrix-M;2;day0-189 with one dose of placebo on day 21&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;25 \u03bcg+50 \u03bcg Matrix-M;2;days0-21 followed by one dose of placebo on day 189&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;25 \u03bcg+50 \u03bcg Matrix-M;1;followed by two doses of placebo on days 21 and 189&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;5 \u03bcg+50 \u03bcg Matrix-M;3;day0-21-189&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;5 \u03bcg+50 \u03bcg Matrix-M;1;followed by two doses of placebo on days 21 and 189&quot;, &quot;treatment_id&quot;: 1158, &quot;treatment_name&quot;: &quot;Sars-cov-2 rs/matrix-m1 adjuvant&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="20769" class="table-">
                
                <td>Oct. 26, 2020, 11:31 p.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo, Day 189 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant, Days 0 and 21 - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Other;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo, Day 21 - Phase 1;SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Other;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo, Day 21 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Day 189 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Other;Biological;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Normal saline solution (NSS), Placebo - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Day 189 - Phase 2;Normal saline solution (NSS), Placebo, Day 21 - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS/Matrix-M Adjuvant, Days 0 and 21 - Phase 2;Normal saline solution (NSS), Placebo, Day 189 - Phase 2&quot;, &quot;treatment_type&quot;: &quot;Biological;Other&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 rS - Phase 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
July 23, 2021, 10:30 p.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo, Day 21 - Phase 1;SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 1", "treatment_type": "Other", "pharmacological_treatment": "Placebo"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 2", "treatment_type": "Other", "pharmacological_treatment": "Placebo"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS - Phase 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]	[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "25 \u03bcg;2;day 0-21", "treatment_id": 1159, "treatment_name": "Sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "5 \u03bcg+50 \u03bcg Matrix-M;2;day 0-21", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25 \u03bcg+50 \u03bcg Matrix-M;2;day0-21", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25 \u03bcg+50 \u03bcg Matrix-M;1;followed by one dose of placebo on day 21", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "5 \u03bcg+50 \u03bcg Matrix-M;2;day0-21 followed by one dose of placebo on day 189", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "5 \u03bcg+50 \u03bcg Matrix-M;2;day0-189 with one dose of placebo on day 21", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25 \u03bcg+50 \u03bcg Matrix-M;2;days0-21 followed by one dose of placebo on day 189", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25 \u03bcg+50 \u03bcg Matrix-M;1;followed by two doses of placebo on days 21 and 189", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "5 \u03bcg+50 \u03bcg Matrix-M;3;day0-21-189", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "5 \u03bcg+50 \u03bcg Matrix-M;1;followed by two doses of placebo on days 21 and 189", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]
Oct. 26, 2020, 11:31 p.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo, Day 189 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant, Days 0 and 21 - Phase 2", "treatment_type": "Other;Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo, Day 21 - Phase 1;SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1", "treatment_type": "Other;Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo, Day 21 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Day 189 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 2", "treatment_type": "Other;Biological;Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 1", "treatment_type": "Other", "pharmacological_treatment": "Placebo"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline solution (NSS), Placebo - Phase 2", "treatment_type": "Other", "pharmacological_treatment": "Placebo"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 2;SARS-CoV-2 rS/Matrix-M Adjuvant - Day 189 - Phase 2;Normal saline solution (NSS), Placebo, Day 21 - Phase 2", "treatment_type": "Biological;Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS/Matrix-M Adjuvant, Days 0 and 21 - Phase 2;Normal saline solution (NSS), Placebo, Day 189 - Phase 2", "treatment_type": "Biological;Other", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 rS - Phase 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]